These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 35503478)

  • 21. Diphenyl diselenide protects a Caenorhabditis elegans model for Huntington's disease by activation of the antioxidant pathway and a decrease in protein aggregation.
    Bicca Obetine Baptista F; Arantes LP; Machado ML; da Silva AF; Marafiga Cordeiro L; da Silveira TL; Soares FAA
    Metallomics; 2020 Jul; 12(7):1142-1158. PubMed ID: 32453327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sir2 is induced by oxidative stress in a yeast model of Huntington disease and its activation reduces protein aggregation.
    Sorolla MA; Nierga C; Rodríguez-Colman MJ; Reverter-Branchat G; Arenas A; Tamarit J; Ros J; Cabiscol E
    Arch Biochem Biophys; 2011 Jun; 510(1):27-34. PubMed ID: 21513696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of RNA-induced toxicity in CAG repeat disorders.
    Nalavade R; Griesche N; Ryan DP; Hildebrand S; Krauss S
    Cell Death Dis; 2013 Aug; 4(8):e752. PubMed ID: 23907466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simple model systems reveal conserved mechanisms of Alzheimer's disease and related tauopathies.
    Jiang Y; MacNeil LT
    Mol Neurodegener; 2023 Nov; 18(1):82. PubMed ID: 37950311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic modifiers of age-at-onset in polyglutamine diseases.
    Chen Z; Sequeiros J; Tang B; Jiang H
    Ageing Res Rev; 2018 Dec; 48():99-108. PubMed ID: 30355507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila.
    Liévens JC; Rival T; Iché M; Chneiweiss H; Birman S
    Hum Mol Genet; 2005 Mar; 14(5):713-24. PubMed ID: 15677486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CAG Expansions Are Genetically Stable and Form Nontoxic Aggregates in Cells Lacking Endogenous Polyglutamine Proteins.
    Zurawel AA; Kabeche R; DiGregorio SE; Deng L; Menon KM; Opalko H; Duennwald ML; Moseley JB; Supattapone S
    mBio; 2016 Sep; 7(5):. PubMed ID: 27677791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A genetic screening strategy identifies novel regulators of the proteostasis network.
    Silva MC; Fox S; Beam M; Thakkar H; Amaral MD; Morimoto RI
    PLoS Genet; 2011 Dec; 7(12):e1002438. PubMed ID: 22242008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FipoQ/FBXO33, a Cullin-1-based ubiquitin ligase complex component modulates ubiquitination and solubility of polyglutamine disease protein.
    Chen ZS; Wong AKY; Cheng TC; Koon AC; Chan HYE
    J Neurochem; 2019 Jun; 149(6):781-798. PubMed ID: 30685895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autophagy genes protect against disease caused by polyglutamine expansion proteins in Caenorhabditis elegans.
    Jia K; Hart AC; Levine B
    Autophagy; 2007; 3(1):21-5. PubMed ID: 17172799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing a peptidylic inhibitor-based therapeutic approach that simultaneously suppresses polyglutamine RNA- and protein-mediated toxicities in patient cells and Drosophila.
    Zhang Q; Tsoi H; Peng S; Li PP; Lau KF; Rudnicki DD; Ngo JC; Chan HY
    Dis Model Mech; 2016 Mar; 9(3):321-34. PubMed ID: 26839389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans.
    Morley JF; Brignull HR; Weyers JJ; Morimoto RI
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10417-22. PubMed ID: 12122205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small-molecule modulators of TRMT2A decrease PolyQ aggregation and PolyQ-induced cell death.
    Margreiter MA; Witzenberger M; Wasser Y; Davydova E; Janowski R; Metz J; Habib P; Sahnoun SEM; Sobisch C; Poma B; Palomino-Hernandez O; Wagner M; Carell T; Jon Shah N; Schulz JB; Niessing D; Voigt A; Rossetti G
    Comput Struct Biotechnol J; 2022; 20():443-458. PubMed ID: 35070167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant E2F activation by polyglutamine expansion of androgen receptor in SBMA neurotoxicity.
    Suzuki E; Zhao Y; Ito S; Sawatsubashi S; Murata T; Furutani T; Shirode Y; Yamagata K; Tanabe M; Kimura S; Ueda T; Fujiyama S; Lim J; Matsukawa H; Kouzmenko AP; Aigaki T; Tabata T; Takeyama K; Kato S
    Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3818-22. PubMed ID: 19237573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polyglutamine expansion in Drosophila: thermal stress and Hsp70 as selective agents.
    Bettencourt BR; Hogan CC; Nimali M
    J Biosci; 2007 Apr; 32(3):537-47. PubMed ID: 17536173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyglutamine expansion diseases: More than simple repeats.
    Silva A; de Almeida AV; Macedo-Ribeiro S
    J Struct Biol; 2018 Feb; 201(2):139-154. PubMed ID: 28928079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expanded polyglutamine domain possesses nuclear export activity which modulates subcellular localization and toxicity of polyQ disease protein via exportin-1.
    Chan WM; Tsoi H; Wu CC; Wong CH; Cheng TC; Li HY; Lau KF; Shaw PC; Perrimon N; Chan HY
    Hum Mol Genet; 2011 May; 20(9):1738-50. PubMed ID: 21300695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An apparent core/shell architecture of polyQ aggregates in the aging Caenorhabditis elegans neuron.
    Fisher RS; Jimenez RM; Soto E; Kalev D; Elbaum-Garfinkle S
    Protein Sci; 2021 Jul; 30(7):1482-1486. PubMed ID: 33966305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurodegeneration caused by polyglutamine expansion is regulated by P-glycoprotein in Drosophila melanogaster.
    Yadav S; Tapadia MG
    Genetics; 2013 Nov; 195(3):857-70. PubMed ID: 24037265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A fine balance between Prpf19 and Exoc7 in achieving degradation of aggregated protein and suppression of cell death in spinocerebellar ataxia type 3.
    Chen ZS; Huang X; Talbot K; Chan HYE
    Cell Death Dis; 2021 Feb; 12(2):136. PubMed ID: 33542212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.